-
Mashup Score: 29
One of the goals of the Ending Metastatic Breast Cancer for Everyone (EMBRACE) program at Dana-Farber Cancer Institute is to provide resources and information to help guide patients through many situations and decisions.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 9Endometrial Cancer Advances | Dana-Farber Cancer Institute - 12 day(s) ago
A new generation of drugs and drug combinations are improving the outlook for patients with endometrial (uterine) cancer.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
With endometrial cancer being the leading cause of death among gynecologic cancers in the U.S., Dana-Farber scientists are tackling the disease from multiple angles to propel a promising new generation of therapies forward. https://t.co/UnmU8ezGl9
-
-
Mashup Score: 236Center for RAS Therapeutics - 16 day(s) ago
The Dana-Farber Center for RAS Therapeutics is a multi-disciplinary initiative that seeks to advance novel treatment approaches to transform the lives of patients with RAS-driven cancers through scientific discovery, translational research, and clinical investigation.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
We’re thrilled to announce the launch of Center for RAS Therapeutics to target the RAS oncogene in cancer. The first of its kind Center aims to advance new treatment approaches for patients with RAS mutant cancers. Learn more: https://t.co/gamUtXX9kO https://t.co/CgMbYRgD1N
-
-
Mashup Score: 21
Jennifer Chan, MD, MPH – Medical Oncology
Source: www.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet-
Paper 5: Encouraging results from the phase 3 #CABINET trial in @NEJM : #cabozantinib ⬆️ PFS in previously treated, advanced extrapancreatic or pancreatic #NET by our own Dr Jen Chan (https://t.co/516GHNlNIv) at @DanaFarber https://t.co/YMfuGM7zct https://t.co/ntN8zqemcM
-
-
Mashup Score: 7Breast Oncology Program | Dana-Farber Cancer Institute - 1 month(s) ago
The Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber provides state-of-the-art and compassionate care for breast cancer patients.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
It's been great to connect at @SABCSSanAntonio! To keep in touch and learn more about Dana-Farber's #breastcancer research, visit us at https://t.co/P2hI6Ph1kO. https://t.co/EKZyl8hD6M
-
-
Mashup Score: 4Dana-Farber researchers to present findings at 2024 San Antonio Breast Cancer Symposium | Dana-Farber Cancer Institute - 2 month(s) ago
Researchers from Dana-Farber Cancer Institute will present more than 30 research studies at the 47th annual San Antonio Breast Cancer Symposium, December 10-13, 2024.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
.@SABCSSanAntonio kicks off next week and we're proud to highlight several exciting abstracts being presented by our @DFCI_BreastOnc faculty. Check out the highlights here. https://t.co/V9tX9vjPiy https://t.co/rh2CMCbtBD
-
-
Mashup Score: 7Cancer Questions | Dana-Farber Cancer Institute - 2 month(s) ago
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
What are the risk factors for #gynecologiccancers? Susanne Menon, NP, women's health nurse practitioner at Dana-Farber, helps break down these factors for prevention & early detection. #GYN https://t.co/KavvN95Ho6 https://t.co/SJEvgjLUT0
-
-
Mashup Score: 7Cancer Questions | Dana-Farber Cancer Institute - 2 month(s) ago
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
What are the risk factors for #gynecologiccancers? Susanne Menon, NP, women's health nurse practitioner at Dana-Farber, helps break down these factors for prevention & early detection. #GYN https://t.co/KavvN95Ho6 https://t.co/SJEvgjLUT0
-
-
Mashup Score: 75
The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering myeloma. The names of the treatment interventions used in this study are: – Cilta-cel (or chimeric antigen receptor T cells) – Cyclophosphamide (a lymphodepleting chemotherapy) – Fludarabine (a lymphodepleting chemotherapy)
Source: www.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet-
The US medical system in all its glory! You can you be completely healthy, get a lab test checked you never needed, and end up receiving a toxic million dollar therapy with risks of secondary cancers and long term neurologic side effects. CAR-PRISM https://t.co/OGkPp1s431
-
-
Mashup Score: 21Dana-Farber Cancer Institute faculty among world's most highly cited researchers | Dana-Farber Cancer Institute - 2 month(s) ago
Dana-Farber Cancer Institute is proud to announce that 42 of its researchers have been named to the Highly Cited Researchers list of 2024, released today by the Institute for Scientific Information at Clarivate.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
This year, @ClarivateAG has recognized more than 40 Dana-Farber faculty members as Highly Cited Researchers, demonstrating significant and broad influence in their field(s) of research. Learn more: https://t.co/fHBBBMjA4O #HighlyCited2024 https://t.co/WU9dV7h45B
-
Join Nancy Lin, MD (@nlinmd) & Sara Tolaney, MD, MPH (@stolaney1) via Zoom for the 1st webinar of the ’24-‘25 EMBRACE #MetastaticBreastCancer Forum Series of free programs for patients on 10/11. Learn about advances & connect with others w #MBC @drsarahsam https://t.co/L4jQHqVjWD https://t.co/PthXulbeFe